San Clemente, CA, Nov. 17, 2020 (GLOBE NEWSWIRE) — via NewMediaWire — The coronavirus disease 2019 (COVID-19) pandemic has placed the world in a tailspin, which the healthcare industry has responded to in kind with the development and rapid deployment of tests designed to detect infection. Many of these tests help clinicians and researchers accurately identify severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19. And while these tests have been crucial in identifying and tracking cases of infection and disease-related morbidity and mortality, they aren’t without their potential drawbacks. Types of COVID-19 Tests   Several new methods have been developed to diagnose COVID-19, many of which have their own alternative methods of administration and unique benefits: Antigen Rapid, point-of-care diagnostic tests: These tests, which can be classified as antigen or, rely on a mucus sample obtained from the throat or nose and is analyzed is used in a rapid device similar to a Flu test, at a clinic or physician’s office. Results from these tests can often be available within minutes. Antibody Rapid, point-of-care diagnostic tests: These tests, which can be classified as serological, rely on fingertip blood obtained from the patient with results in minutes. Molecular: These tests, which   Read more…